Evaluation of the intestinal environment for pregnant women and infants
- Conditions
- Healthy pregnant women
- Registration Number
- JPRN-UMIN000043094
- Lead Sponsor
- Metabologenomics, Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 30
Not provided
(1) Subjects who are currently receiving medication. (2) Subjects who are diagnosed with gestational diabetes or gestational hypertension. (3) Subjects who have consumed medicines which affect the intestinal environment within the last 1 month to the observation start. (4) Subjects who have current medical history/anamnesis of severe cardiac, hepatic, renal or digestive diseases. (5) Subjects who are heavy use of alcohol. (6) Smokers. (7) Subjects who have extremely irregular dietary habits,working hours or daily rhythms. (8) Subjects who are currently participating, or who have participated in other study for medicine or food within the last 4 weeks of the present study, or who possibly participate in another clinical trial after agreement of this study. (9) Subjects who have been determined ineligible by principal investigator or sub-investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intestinal microbiome and intestinal metabolome
- Secondary Outcome Measures
Name Time Method Child atopy and eczema incidence rate (48 weeks old)